Keep an eye on this stock, which was locked in the upper circuit on November 18 Keep an eye on this stock, which was locked in the upper circuit on November 18 Today, the stock of this company was locked at 20 per cent upper circuit at Rs 70.10. Kiran Shroff / Friday, November 18, 2022 / Article rating: 4.1 Today, the stock of this company was locked at 20 per cent upper circuit at Rs 70.10.
This BSE small-cap top gainer climbed over 13 per cent today; do you own it? This BSE small-cap top gainer climbed over 13 per cent today; do you own it? The rally was majorly due to the positive results that the company posted for Q2FY23. Kiran Shroff / Wednesday, November 16, 2022 / Article rating: 4.5 This BSE small-cap top gainer climbed over 13 per cent today; do you own it?
From Rs 160 to Rs 827: This multi-bagger stock has gained over 392 per cent year to date; to pay 6:1 bonus share soon From Rs 160 to Rs 827: This multi-bagger stock has gained over 392 per cent year to date; to pay 6:1 bonus share soon The stock has increased by 392 per cent, while the BSE Sensex has increased just by 4.41per cent Kiran Shroff / Wednesday, November 16, 2022 / Article rating: 4.4 The stock has increased by 392 per cent, while the BSE Sensex has increased just by 4.41per cent.
Keep an eye on this stock, which was locked in the upper circuit on November 15 Keep an eye on this stock, which was locked in the upper circuit on November 15 Today, the stock of this company was locked at 20 per cent at Rs 139.80 Kiran Shroff / Tuesday, November 15, 2022 / Article rating: 4.1 Today, the stock of this company was locked at 20 per cent at Rs 139.80.
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. Kiran Shroff / Tuesday, November 15, 2022 / Article rating: 4.3 This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.
This pharma company stock went 8 per cent high, do you own it? This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Kiran Shroff / Thursday, November 10, 2022 / Article rating: 5.0 This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.
Do you own this power stock that got approval for a 150 MW solar project? Do you own this power stock that got approval for a 150 MW solar project? This company receives ‘Letter of Award’ to set up a 150 MW Solar project in Maharashtra Kiran Shroff / Thursday, November 10, 2022 / Article rating: 4.4 Do you own this power stock that got approval for a 150 MW solar project? This company receives a ‘Letter of Award’ to set up a 150 MW Solar project in Maharashtra
Upcoming collaboration: Two leading pharma company stocks to watch out for Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns Kiran Shroff / Wednesday, November 9, 2022 / Article rating: 4.5 Upcoming collaboration: Two leading pharma company stocks to watch out for US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.
This automobile stock zoomed 4 per cent on its collaboration with Amazon; do you own it? This automobile stock zoomed 4 per cent on its collaboration with Amazon; do you own it? Strategic engagement will permit the 2 corporations to collaborate on the electric-powered two-wheeler segment and three-wheeler segment, helping to further drive electric mobility in India. Kiran Shroff / Wednesday, November 9, 2022 / Article rating: 4.9 This automobile stock zoomed 4 per cent on its collaboration with Amazon; do you own it?
Stocks below Rs 100: Only buyers seen in these scrips on October 6 Stocks below Rs 100: Only buyers seen in these scrips on October 6 The FIIs bought equity worth Rs 1,344.63 crore on Tuesday (October 4) while the DIIs bought equity for a net worth of Rs 945.92 crore. Sayali Kotwal / Thursday, October 6, 2022 / Article rating: 4.0 At 1 pm on Thursday, the headline equity indices, i.e. Sensex and Nifty 50 are trading marginally higher amidst extreme market volatility in the US markets. The FIIs bought equity worth Rs 1,344.63 crore on Tuesday (October 4) while the DIIs bought equity for a net worth of Rs 945.92 crore.